Loading...
Upexi, Inc.
GRVI•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$4.95
$0.35(7.61%)
Upexi, Inc. (GRVI) Financial Performance & Income Statement Overview
Review Upexi, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-67.77%
↓ 67.77%
Operating Income Growth
-197.44%
↓ 197.44%
Net Income Growth
-39.74%
↓ 39.74%
Operating Cash Flow Growth
-1045.49%
↓ 1045.49%
Operating Margin
5.92%
↑ 5.92%
Gross Margin
49.38%
↑ 49.38%
Net Profit Margin
12.36%
↑ 12.36%
ROE
27.78%
↑ 27.78%
ROIC
6.66%
↑ 6.66%
Upexi, Inc. (GRVI) Income Statement & Financial Overview
Review Upexi, Inc.'s (GRVI) income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $4.005M | $4.36M | -$37.62M | $14.44M |
| Cost of Revenue | $1.03M | $1.43M | -$30.58M | $11.56M |
| Gross Profit | $2.97M | $2.93M | -$7.04M | $2.88M |
| Gross Profit Ratio | $0.74 | $0.67 | $0.12 | $0.20 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $3.81M | $2.41M | $1.95M | $6.45M |
| Operating Expenses | $4.05M | $2.41M | $7.56M | $7.82M |
| Total Costs & Expenses | $5.08M | $3.84M | -$23.02M | $19.38M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $290412.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $239752.00 | $0.00 | -$4.84M | $1.13M |
| EBITDA | -$833447.00 | -$1.34M | -$24.36M | -$3.81M |
| EBITDA Ratio | -$0.21 | -$0.31 | $0.73 | -$0.26 |
| Operating Income | -$1.07M | -$1.34M | -$14.60M | -$4.94M |
| Operating Income Ratio | -$0.27 | -$0.31 | $0.43 | -$0.34 |
| Other Income/Expenses (Net) | -$228111.00 | -$290412.00 | -$259498.00 | -$765141.00 |
| Income Before Tax | -$1.30M | -$1.63M | -$14.86M | -$5.70M |
| Income Before Tax Ratio | -$0.32 | -$0.37 | $0.45 | -$0.39 |
| Income Tax Expense | $0.00 | $0.00 | $2.34M | -$1.50M |
| Net Income | -$1.30M | -$1.63M | -$15.75M | -$4.12M |
| Net Income Ratio | -$0.32 | -$0.37 | $0.48 | -$0.29 |
| EPS | -$1.24 | -$1.55 | -$15.33 | -$3.97 |
| Diluted EPS | -$1.24 | -$1.55 | -$15.33 | -$3.97 |
| Weighted Avg Shares Outstanding | $1.05M | $1.05M | $1.03M | $1.04M |
| Weighted Avg Shares Outstanding (Diluted) | $1.05M | $1.05M | $1.03M | $1.04M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan